ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1269

Implementing RAPID-3 Using Electronic Patient Portal and Point of Care Entry

Sancia Ferguson1, Lori Zemlicka2, Amanda Weber2, Abdul Halabi3, Jon Arnason4 and Christie Bartels5, 1University of Wisconsin School of Medicine & Public Health, Madison, WI, 2UW Health, Madison, WI, 3University of Wisconsin, Madison, WI, 4University of Wisconsin Hospitals and Clinics, Madison, WI, 5University of Wisconsin School of Medicine and Public Health, Madison, WI

Meeting: ACR Convergence 2022

Keywords: Disease Activity, Intervention, Measurement, Patient reported outcomes, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Measures and Measurement of Healthcare Quality Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: The treat-to-target approach endorsed by the ACR for rheumatoid arthritis requires frequent monitoring of disease activity using validated instruments, with changes to the treatment regimen in order to target low disease activity or remission. The two university rheumatology clinics were using the Routine Assessment of Patient Index Data with 3 measures (RAPID-3) to measure disease activity. Historically, this had been given to the patient on paper at the time of an in-person clinic visit. Barriers to collecting RAPID-3 included; time taken at the beginning of the visit, incomplete form collection, manual entry into the electronic health record (EHR), and COVID-19 workflow changes resulting in gaps. We implemented electronic patient portal entry and point of care entry to address these barriers, with the goal of improving our collection rate.

Methods: Baseline RAPID-3 data (7/2020 – 11/2021) were presented for patients with RA at both clinic sites prior to implementation during a monthly faculty meeting with a discussion of the importance of collecting disease activity measures. Barriers and facilitators to paper collection and future implementation of the patient portal and point of care electronic entry were discussed with faculty and in clinical support team huddles. Using the Consolidated Framework for Implementation Research (CFIR) Barrier Buster Tool (v0.52) we identified barriers that were mapped to Expert Recommendations for Implementing Change (ERIC) strategies to facilitate implementation (Table 1). A multidisciplinary team including physicians, nursing, and clinic leadership, and electronic health records analysts was formed to adapt the RAPID-3 tool for electronic patient portal use, and develop an implementation blueprint. The health IT converted paper tools into electronic items that were viewable on phones, tablets, and computer. This required adaptation of the visual analogue scale for phone (Fig 1A). Results are viewable within the encounter template (Fig 1B). Electronic tools went live 1/24/2022. Pre and 3-month post-implementation completion rates were compared using Fischer’s exact test.

Results: At baseline 36.2% of RA patient encounters at clinic site A and 9.3% at clinic site B had RAPID-3 scores entered (n = 317/875, 76/817; Fig 2 ). Following RAPID-3 faculty discussion, scores temporarily increased to 48.1% and 13% for sites A and B respectively. After patient portal and point of care electronic entry began, rates rose to 86% and 82%. Modest declines were noted afterwards with a 3-month average of 79.5% across all clinic encounters (n= 594/749, p < 0.001). For all patients who completed RAPID-3, 55.7% responded using the patient portal prior to visit.

Conclusion: Implementing electronic patient entered and point of care RAPID-3 assessments for RA significantly increased completion. Future efforts will include implementation strategies to support continued RAPID-3 collection and use in patient encounters.

Supporting image 1

Supporting image 2

Implementation strategies used to address barriers to electronic patient portal and point of care entry of RAPID_3

Supporting image 3

RAPID_3 data collection pre and post Intervention


Disclosures: S. Ferguson, None; L. Zemlicka, None; A. Weber, None; A. Halabi, None; J. Arnason, None; C. Bartels, Pfizer.

To cite this abstract in AMA style:

Ferguson S, Zemlicka L, Weber A, Halabi A, Arnason J, Bartels C. Implementing RAPID-3 Using Electronic Patient Portal and Point of Care Entry [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/implementing-rapid-3-using-electronic-patient-portal-and-point-of-care-entry/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/implementing-rapid-3-using-electronic-patient-portal-and-point-of-care-entry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology